Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Pharmacovigilance and Risk Management Strategies Conference
Session 8: ABSTRACT SESSION
Session Chair(s)
Lisa Melanie Harinstein, PharmD
- Team Leader, Division of Pharmacovigilance, FDA
- FDA, United States
For the first time at the DIA Pharmacovigilance and Risk Management Strategies Conference, this new session will feature four presentations selected from an abstract submission process. This session will explore the innovative use of pharmacoepidemiology studies, real world evidence, social media, and signal management tools in pharmacovigilance.
Speaker(s)

Ruben Ayzin Rosoky, MD, PhD
- Sr Safety Physician
- United Biosource Corp., France
The European IV Iron PASS Consortium: Experiences from Coordinating a Multi-Company, Multi-Registry PASS
Michael Forstner, PhD
- Head of Clinical and Patient Safety
- Biogen BBU, Switzerland
Innovative Pharmacovigilance (PV) Solution in Social Media: Compliance, Signaling, and Social Media Footprint
Jennifer B Hannan, MS
- Director, Pharmacovigilance Business Liaison
- Merck & Co., Inc., United States
Evaluation of Different Signal Management Tools: New Regulatory Perspectives
Sanjeev Miglani, MD
- Founder and Director
- AWINSA Life Sciences, United States
The Value of RWD in Safety Signal Refinement
Irene Cosmatos, MS
- Senior Research Specialist, Database Analytics Automation
- UBC, United States
Contact us
Customer Service
Preconference Short Courses
Short Course 1: Introduction to Pharmacoepidemiology
Short Course 2: Pharmacovigilance and Risk Management Planning
Short Course 3: Reference Safety Information
Short Course 4: Combination Therapies